NCT04187339View on ClinicalTrials.gov

Study of NGM395 in Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 13, 2020

Primary Completion Date

October 20, 2020

Study Completion Date

April 22, 2021

Conditions
ObesityNAFLD
Interventions
BIOLOGICAL

NGM395

NGM395 Dose 1

BIOLOGICAL

NGM395

NGM395 Dose 2

BIOLOGICAL

NGM395

NGM395 Dose 3

BIOLOGICAL

NGM395

NGM395 Dose 4

BIOLOGICAL

NGM395

NGM395 Dose 5

BIOLOGICAL

NGM395

NGM395 Dose 6

OTHER

Placebo

Placebo

Trial Locations (1)

Unknown

NGM Clinical Study Site, Brisbane

Sponsors
All Listed Sponsors
lead

NGM Biopharmaceuticals, Inc

INDUSTRY

NCT04187339 - Study of NGM395 in Adult Participants | Biotech Hunter | Biotech Hunter